Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Cyclophosphamide for Injection

Approval Number

国药准字HJ20160467

CompanyBaxter Deutschland GmbH

Registration Date

June 8, 2021

Previous Approval Numbers

H20160467

Drug Information

Generic Name

注射用环磷酰胺

Trade Name

安道生

Brand Name

安道生

Dosage Form

注射剂

Strength

0.2g

Drug Type

化学药品

Registration Date

June 8, 2021

Expiry Date

June 7, 2026

Company Information

Applicant Company

Company NameBaxter Deutschland GmbH

Company Address

Edisonstrasse 4 85716 Unterschleissheim Germany

Manufacturing Company

Company NameBaxter Oncology GmbH

Company Address

Kantstr.2 33790 Halle Germany

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

注射用环磷酰胺 - NMPA 批准文号 | MedPath